Jan Menne

4.6k total citations · 1 hit paper
59 papers, 3.0k citations indexed

About

Jan Menne is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jan Menne has authored 59 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Cardiology and Cardiovascular Medicine, 20 papers in Nephrology and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jan Menne's work include Blood Pressure and Hypertension Studies (32 papers), Chronic Kidney Disease and Diabetes (17 papers) and Heart Rate Variability and Autonomic Control (13 papers). Jan Menne is often cited by papers focused on Blood Pressure and Hypertension Studies (32 papers), Chronic Kidney Disease and Diabetes (17 papers) and Heart Rate Variability and Autonomic Control (13 papers). Jan Menne collaborates with scholars based in Germany, United States and Spain. Jan Menne's co-authors include Hermann Haller, Danilo Fliser, Luís M. Ruilope, Jens Jordan, Eberhard Ritz, Giancarlo Viberti, Ton J. Rabelink, Ferdinand H. Bahlmann, Sadayoshi Ito and Andrzej Januszewicz and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jan Menne

57 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

2011 522 citations Hermann Haller, Sadayoshi Ito et al. profile →

Peers

Countries citing papers authored by Jan Menne

Since Specialization

Citations

This map shows the geographic impact of Jan Menne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Menne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Menne more than expected).

Fields of papers citing papers by Jan Menne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Menne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Menne. The network helps show where Jan Menne may publish in the future.

Co-authorship network of co-authors of Jan Menne

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Menne. A scholar is included among the top collaborators of Jan Menne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Menne. Jan Menne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of a biomimetic pathogen adsorbing device on inflammatory biomarkers in COVID‐19 patients 2024 ·Therapeutic Apheresis and Dialysis ·(unknown), Thomas Fuehner, (unknown), Tobias Welte, Jan Menne, Jan Fuge, (unknown), Andrea Paul, (unknown), (unknown), Christine S. Falk, Jan T. Kielstein	0
2	Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice 2020 ·PLoS ONE ·(unknown), Nelli Shushakova, Heiko Schenk, (unknown), (unknown), Jan Menne, Hermann Haller	17
3	Protein kinase C α inhibition prevents peritoneal damage in a mouse model of chronic peritoneal exposure to high-glucose dialysate 2016 ·Kidney International ·(unknown), Michael S. Balzer, Song Rong, Jan Menne, Sibylle von Vietinghoff, Lei Dong, Faikah Gueler, Mi-Sun Jang, Gang Xu, Kai Timrott, Sergey Tkachuk, Marcus Hiß, Hermann Haller, Nelli Shushakova	24
4	Long-Term Effects of 3-Month Telemetric Blood Pressure Intervention in Patients with Inadequately Treated Arterial Hypertension 2015 ·Telemedicine Journal and e-Health ·C. Neumann, Jan Menne, Volker Schettler, (unknown), (unknown), Hermann Haller, (unknown)	11
5	Spike rate of multi-unit muscle sympathetic nerve fibers after catheter-based renal nerve ablation 2015 ·Journal of the American Society of Hypertension ·Jens Tank, Karsten Heusser, Julia Brinkmann, Bernhard M. W. Schmidt, Jan Menne, Johann Bauersachs, Hermann Haller, André Diedrich, Jens Jordan	8
6	The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) Observational Follow‐Up Study: Benefits of RAS Blockade With Olmesartan Treatment Are Sustained After Study Discontinuation 2014 ·Journal of the American Heart Association ·Jan Menne, Eberhard Ritz, Luís M. Ruilope, Christos Chatzikyrkou, Giancarlo Viberti, Hermann Haller	35
7	Prevention of electrocardiographic left ventricular remodeling by the angiotensin receptor blocker olmesartan in patients with type 2 diabetes 2014 ·Journal of Hypertension ·Ulrike Raff, Christian Ott, Luís M. Ruilope, Jan Menne, Hermann Haller, Roland E. Schmieder	5
8	Catheter-Based Renal Nerve Ablation and Centrally Generated Sympathetic Activity in Difficult-to-Control Hypertensive Patients 2012 ·Hypertension ·Julia Brinkmann, Karsten Heusser, Bernhard M. W. Schmidt, Jan Menne, Gunnar Klein, Johann Bauersachs, Hermann Haller, Fred C.G.J. Sweep, André Diedrich, Jens Jordan, Jens Tank	118
9	Resistant hypertension: baroreflex stimulation as a new tool 2012 ·Nephrology Dialysis Transplantation ·Jan Menne, Jens Jordan, Silvia Linnenweber-Held, Hermann Haller	10
10	Diabetische Nephropathie 2011 ·Der Internist ·Jan Menne, Hermann Haller	3
11	Pathogenesis and management of hypertension after kidney transplantation 2011 ·Journal of Hypertension ·Christos Chatzikyrkou, Jan Menne, Wilfried Gwinner, Bernhard M. W. Schmidt, Frank Lehner, Cornelia Blume, Anke Schwarz, Hermann Haller, Mario Schiffer	32
12	Carotid Baroreceptor Stimulation, Sympathetic Activity, Baroreflex Function, and Blood Pressure in Hypertensive Patients 2010 ·Hypertension ·Karsten Heusser, Jens Tank, Stefan Engeli, André Diedrich, Jan Menne, Siegfried Eckert, T. J. Peters, Fred C.G.J. Sweep, Hermann Haller, (unknown), Friedrich C. Luft, Jens Jordan	307
13	Prevention of microalbuminuria in type 2 diabetes (ROADMAP Trial) 2010 ·Diabetologia ·Hermann Haller, Seiki Ito, Joseph L. Izzo, Andrzej Januszewicz, Shigehiro Katayama, Jan Menne, A Mimran, Ton J. Rabelink, Eberhard Ritz, Luís M. Ruilope, L. C. Rump, Giancarlo Viberti	3
14	Novel Baroreflex Activation Therapy in Resistant Hypertension 2010 ·Journal of the American College of Cardiology ·Ingrid Scheffers, Abraham A. Kroon, Jürg Schmidli, Jens Jordan, (unknown), Markus G. Mohaupt, Friedrich C. Luft, Hermann Haller, Jan Menne, Stefan Engeli, Jiří Ceral, Siegfried Eckert, Andrejs Ērglis, Krzysztof Narkiewicz, Thomas Philipp, Peter W. de Leeuw	244
15	Microalbuminuria as a risk factor: the influence of renin–angiotensin system blockade 2010 ·Journal of Hypertension ·Jan Menne, Christos Chatzikyrkou, Hermann Haller	20
16	Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study 2009 ·Diabetologia ·Eberhard Ritz, G. C. Viberti, Luís M. Ruilope, Ton J. Rabelink, (unknown), Shigehiro Katayama, Sadayoshi Ito, A Mimran, Jan Menne, L. C. Rump, Andrzej Januszewicz, Hermann Haller	36
17	How to achieve renal protection in the light of ONTARGET? 2009 ·Journal of Hypertension ·Christos Chatzikyrkou, Jan Menne, Hermann Haller	5
18	Chronic erythropoietin treatment affects different molecular pathways of diabetic cardiomyopathy in mouse 2009 ·European Journal of Clinical Investigation ·Nelli Shushakova, (unknown), Jan Menne, Danilo Fliser	9
19	Fixed-dose lercanidipine/enalapril for hypertension 2008 ·Drugs of today ·Jan Menne, Hermann Haller	6
20	Postischemic Acute Renal Failure Is Reduced by Short-Term Statin Treatment in a Rat Model 2002 ·Journal of the American Society of Nephrology ·Faikah Gueler, Song Rong, Joon-Keun Park, Anette Fiebeler, Jan Menne, Marlies Elger, Dominik Mueller, Franziska Hampich, Ralf Dechend, Uta Kunter, Friedrich C. Luft, Hermann Haller	112

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact